Tucson, Arizona--(Newsfile Corp. - August 28, 2024) - NuvOx Therapeutics, Inc., a Phase IIb clinical stage biotech company that specializes in first in class nanobubble oxygen therapeutics platform, today announced that the company is scheduled to present at the 150th National Investment Banking Association (NIBA) Investment Conference on...